Netanya, Isreal telemedicine outfit Tyto Care, which specializes in incorporating connected devices into telemedicine encounters, has secured a CE Mark, allowing it to expand its offerings into Europe.
Tyto Care’s offering includes a suite of connected devices designed to give remote doctors every tool that would be available in an in-person visit: a connected otoscope, stethoscope, basal thermometer and digital camera.
The tools are designed to be self-guiding, allowing patients to conduct their own exams and forward them to a clinician or to use the tools during a live video chat.
The company ultimately plans to sell a direct-to-consumer offering called TytoHome, but currently works with health systems, employers and other telemedicine companies. It will gradually roll out in Europe the same way.
"Receiving CE Mark approval is an important milestone for Tyto Care, and a major step in our continued strategic expansion into Europe and other new markets," Dedi Gilad, CEO and cofounder of Tyto Care, said in a statement. "European doctors are struggling to keep up with the increasing medical demand of an aging population and the rise of chronic illnesses. Tyto is uniquely positioned to ease this burden by replicating the quality of in-person doctors' visits without any barriers to access such as transportation and wait time. We look forward to working with European partners to provide this critical missing link and transform the delivery of traditional primary care.”
TytoCare received FDA clearance for its platform in the fall of 2016 and has been operating in the United States since last year.
The company teased a planned expansion into not only Europe but Asia as well when it raised a $25 million Series B in January. That round was led by Chinese insurance giant Ping An.
Consumers interested in TytoHome can currently sign up for a wait list, but the company hasn’t committed to a price range for the service.